COVID-19: Gilead To Fill Remdesivir Supply Gap In EU
Coronavirus Reignites Compulsory Licensing Debate
Executive Summary
As the US firm prepares to ramp up production of the antiviral for use in coronavirus patients, a debate is growing over whether changes could be made to EU rules that prevent the importation of generic drugs produced under a compulsory license.